I VACCINI CAUSANO L' AUTISMO

di Gianni Lannes

Ecco una ricerca scientifica documentata, sicuramente sfuggita al nobel tricolore Beatrice Lorenzin (ministro uscente da processare per direttissima), che ha confuso i virus con i batteri saltellanti.  Se invece degli spot propagandistici la comunità scientifica italiana presentasse gli studi di chi sta indagando sui possibili legami fra vaccini e autismo, l’opinione pubblica scoprirebbe che, sul banco degli imputati, compaiono i vaccini coniugati, le vaccinazioni plurime.  

Soltanto dei criminali in camice bianco e dei politicanti italidioti possono ancora negare una correlazione e tentare di imporre ben 12 vaccini in da modalità di trattamento sanitario obbligatorio. Negli Stati uniti d’America l’incidenza dell’autismo è superiore a qualsiasi malattia infettiva: 1 su 68 (nel 1975 era 1 su 5 mila) mentre nella popolazione Amish che non è solita praticare alcun vaccino, la malattia ha un’incidenza bassissima, 1 ogni 10.000.

In termini matematici, il vaccino incrementa la probabilità di autismo di ben147 volte. Grazie, dunque, alla popolazione Amish per aver fornito, sia pure indirettamente, un ottimo campione statistico di confronto. Il danno da vaccini è causa documentata di autismo. I dati sull'incidenza e prevalenza indicano che il momento di introduzione dei vaccini e le modificazioni nel tipo e nell'incremento del numero dei vaccini inoculati contemporaneamente implica che i vaccini sono causa di autismo.

Perché Aifa ha nascosto i rapporti degli ultimi 3 anni? Perché nel rapporto Osmed 2014 (quello generico su farmaci e vaccini) emerge che sono aumentati i casi psichiatrici sotto i due anni?  

A proposito: dove sono gli studi di sicurezza e di efficacia dei nuovi vaccini? Chi si fiderebbe dell'antimeningocco B (malattia rarissima) leggendo il rapporto ISTISAN dell'Istituto superiore di sanità? Nessun genitore che ha letto quel documento sottoporrà i propri figli alla pericolosa vaccinazione.   Alla repressione istituzionale messa in atto per conto terzi dai mentecatti di Stato e dagli analfabeti funzionali, segue la ribellione naturale. Nessuno ha il diritto di attentare alla vita anche di un solo essere umano.

Riferimenti

http://www.rescuepost.com/files/theoretical-aspects-of-autism-causes-a-review1.pdf

http://www.ageofautism.com/2011/02/new-medical-journal-review-vaccine-injury-is-a-documented-cause-of-autism.html#comments

http://ecdc.europa.eu/en/publications/Publications/9910_SUR_Evaluation_of_Haemophilus_Influenzae_type_b_vaccination.pdf

http://www.dds.ca.gov/autism/docs/AutismReport_2007.pdf

http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Product_Information/human/000296/WC500032505.pdf

http://www.assis.it/informazioni-sui-vaccini-quel-che-laifa-dice-e-quello-che-non-dice/

Atkinson W, Wolfe S, Hamborsky J, McIntyre L, editors. Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. Washington, DC: Public Health Foundation; 2009. p. 71–83, 217–30.

PHLS Communicable Disease Surveillance Centre. An evaluation of Haemophilus influenzae type B (Hib) vaccination and description of risk factors for HIB vaccine failures in Europe 1996–1998. Final report. London; October 1999. http://www.ecdc.europa.eu/e…/9910_SUR_Evaluation_of_Haemophilus_Influenzae_type_b_vaccination.pdf [24.09.11].

Centers for Disease Control and Prevention. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older recommendations of the ACIP. Morbidity and mortality weekly report (MMWR); January 11, 1991/40(RR01). p. 1–7.

Goldblatt D. Conjugate vaccines. Clin Exp Immunol 2000;119(1):1–3.

Murphy K, Travers P, Walport M. Janeway’s immuno biology. 7th ed. New York, NY: Garland Science; 2008. p. 381–4, 396–9, 400–2, 691–2.

Coico R, Sunshine G. Immunology: a short course. 6th ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2009. p. 101–2, 151, 158–9.

Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res 2009;65(6):591–8.

Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, United States, 2006. MMWR Surveill Summ 2009;58(SS10):1–20.

Scahill L, Bearss K. The rise in autism and the mercury myth. J Child Adolesc Psychiatr Nurs 2009;22(1):51–3.

Charman T. The prevalence of autism spectrum disorders. Recent evidence and future challenges. Eur Child Adolesc Psychiatry 2002;11(6):249–56.

McDonald ME, Paul JF. Timing of increased autistic disorder cumulative incidence. Environ Sci Technol 2010;44(6):2112–8.

Newschaffer CJ, Falb MD, Gurney JG. National autism prevalence trends from United States special education data. Pediatrics 2005;115(3):e277–82.

Gurney JG, Fritz MS, Ness KK, Sievers P, Newschaffer CJ, Shapiro EG. Analysis of prevalence trends of autism spectrum disorder in Minnesota. Arch Pediatr Adolesc Med 2003;157:622–7.

Lauristen MB, Pedersen CB, Mortensen PB. The incidence and prevalence of pervasive developmental disorders: a Danish population-based study. Psychol Med 2004;34(7):1339–46.

Senecky Y, Chodick G, Diamond G, Lobel D, Drachman R, Inbar D. Time trends in reported autistic spectrum disorders in Israel, 1972–2004. Isr Med Assoc J 2009;11(1):30–3.

Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 2011;1380:42–77.

Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong association of de novo number mutations with autism. Science 2007;316(5823):445–9.

Lintas C, Sacco R, Persico AM. Genome-wide expression studies in Autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiol Dis 2010 [Epub ahead of print].

Careaga M, Van de Water J, Ashwood P. Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 2010;7(3):283–92.

Cabanlit M, Wills S, Goines P, Ashwood P, Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci 2007;1107:92–103.

Mostafa GA, El-Sayed ZA, El-Aziz MM, El-Sayed MF. Serum anti-myelinassociated glycoprotein antibodies in Egyptian autistic children. J Child Neurol 2008;23(12):1413–8.

Vojdani A, Campbell AW, Anyanwu E, Kashanian A, Bock K, Vojdani E. Antibodies to neuron-specific antigens in children with autism: possible crossreaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol 2002;129(1–2):168–77.

Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009;207(1–2):111–6.

Enstrom A, Krakowiak P, Onore C, Pessah IN, Hertz-Picciotto I, Hansen RL, et al. Increased IgG4 levels in children with autism disorder. Brain Behav Immun 2009;23:389–95.

Atladottir HO, Pedersen MG, Scient C, Thorsen P, Mortensen PB, Deleuran B, et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009;124(2):687–94.

Goines P, Van de Water J. The immune system’s role in the biology of autism. Curr Opin Neurol 2010;23(2):111–7.

Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health 2007;28:235–58.

 Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine of the National Academies (US). Immunization safety review: vaccines and autism. Washington DC: The National Academies Press; 2004. http://www.nap.edu…030909237X [24.09.11].

Honda H, Shimizu Y, Rutter M. No effect ofMMRwithdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry 2005;46(6):572–9.

Pugh-Bernard AE, Silverman GJ, Cappione AJ, Villano ME, Ryan DH, Insel RA, et al. Regulation of inherently autoreactive VH4–34 B cells in the maintenance of human B cell tolerance. J Clin Invest 2001;108(7):1061–70.

Adderson EE, Shackelford PG, Quinn A, Wilson PM, Cunningham MW, Insel RA, et al. Restricted immunoglobulin VH usage and VDJ combinations in the human response to Haemophilus influenzae type b capsular polysaccharide. J Clin Invest 1993;91:2734–43.

Lucas AH, Larrick JW, Reason DC. Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. Infect Immun 1994;62(9):3873–80.

California Health and Human Services Agency, Department of Developmental Services. Autistic spectrum disorders. Changes in California caseload. An update: June 1987 through June 2007. 

Sacramento, CA: California Health and Human Services Agency, Department of Developmental Services; 2003. http://www.dds.ca.gov/…/AutismReport_2007.pdf [24.09.11].

Aubert-Broche B, Fonov V, Leppert I, Pike GB, Collins DL. Human brain myelination from birth to 4.5 years. Med Image Comput Comput Assist Interv 2008;11(pt. 2):180–7.

Peltola K, Aavitsland P, Hansen KG, Jonsdottir KE, Nokleby H, Romanus V. Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. J Infect Dis 1999;179(1):223–9.

Kelly Dominic F , et alt Haemophilus influenzae type b conjugate vaccines http://www.ncbi.nlm.nih.gov/…/PMC1782565/